Corteva, Inc. (NYSE:CTVA) Shares Sold by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 8.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 35,753 shares of the company’s stock after selling 3,244 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Corteva were worth $1,713,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CTVA. WCM Investment Management LLC grew its position in Corteva by 3.1% during the 4th quarter. WCM Investment Management LLC now owns 7,103,146 shares of the company’s stock worth $341,590,000 after purchasing an additional 213,949 shares in the last quarter. 17 Capital Partners LLC purchased a new position in shares of Corteva during the 4th quarter valued at $1,649,000. Factory Mutual Insurance Co. grew its holdings in shares of Corteva by 10.7% during the 4th quarter. Factory Mutual Insurance Co. now owns 532,558 shares of the company’s stock valued at $25,520,000 after acquiring an additional 51,500 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in shares of Corteva by 9.7% during the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 777,833 shares of the company’s stock valued at $39,794,000 after acquiring an additional 68,593 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of Corteva by 1.1% during the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,760,701 shares of the company’s stock valued at $132,293,000 after acquiring an additional 31,171 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Down 2.5 %

Corteva stock opened at $54.13 on Wednesday. The firm has a market cap of $37.83 billion, a price-to-earnings ratio of 53.07, a P/E/G ratio of 1.44 and a beta of 0.77. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.56 and a quick ratio of 0.90. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $61.87. The firm has a fifty day moving average price of $55.29 and a two-hundred day moving average price of $50.54.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The firm had revenue of $3.71 billion during the quarter, compared to analyst estimates of $3.54 billion. During the same quarter in the previous year, the business earned $0.16 EPS. As a group, analysts forecast that Corteva, Inc. will post 2.84 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Tuesday, June 4th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $0.64 annualized dividend and a dividend yield of 1.18%. Corteva’s payout ratio is 62.75%.

Analyst Ratings Changes

CTVA has been the topic of several research analyst reports. Mizuho lowered their price target on shares of Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. BNP Paribas upgraded shares of Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price target on the stock in a report on Friday, February 2nd. Wells Fargo & Company boosted their price target on shares of Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Wolfe Research started coverage on shares of Corteva in a report on Friday, March 1st. They set an “outperform” rating and a $67.00 price target on the stock. Finally, Royal Bank of Canada lifted their price objective on shares of Corteva from $56.00 to $64.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average target price of $63.29.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.